Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting


Por: Bermudez, J, Garcia, I, Urzaiz, M, Marrero, P, Cepero, M, Llarena, R, Martin, J, Vivas-Perez, J, Aliaga, M and Soto, A

Publicada: 1 sep 2019
Categoría: Urology

Resumen:
Introduction and objectives: Nivolumab is an immunotherapy agent that has been an approved treatment for previously treated patients with advanced renal cell carcinoma (RCC). Experience in real-life settings, especially regarding immune-related adverse events, is scarce. We present our experience with reference to the safety of nivolumab in patients with metastatic RCC (mRCC) treated in 9 hospitals in Spain. Material and methods: Retrospective, multicentre study of patients with mRCC treated with nivolumab between 2016 and 2018. Data on baseline socio-demographic and clinical characteristics and drug-related adverse events were collected. Results: The mean age of the 26 patients included was 63.7 11.5 years; 96% were ECOG 0-1 and 78% had favourable or intermediate MSKCC risk scores; 73% had the clear cell histological subtype and 30% metastatic disease. Median follow-up was 9 months (range 1-14). All patients experienced an adverse event at different grades, with fatigue, fever and anaemia being the most common (27%). Grade 3 adverse events occurred in 23% of patients. Adverse reactions led to treatment suspension in 3 patients (11%). Conclusion: In the real-life clinical setting, nivolumab shows favourable outcomes, similar to those reported by other studies. (C) 2019 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.

Filiaciones:
Bermudez, J:
 Hosp Univ Jerez, Serv Urol, Jerez de la Frontera, Spain

Garcia, I:
 Hosp Virgen del Rocio, Serv Urol, Seville, Spain

Urzaiz, M:
 Hosp Univ Basurto, Serv Urol, Bilbao, Spain

Marrero, P:
 Hosp Univ Dr Negrin, Serv Urol, Las Palmas Gran Canaria, Spain

Cepero, M:
 Hosp Univ Puerta del Mar, Serv Urol, Cadiz, Spain

Llarena, R:
 Hosp Cruces, Serv Urol, Baracaldo, Spain

Martin, J:
 Complejo Hosp Jaen, Serv Urol, Jaen, Spain

Vivas-Perez, J:
 Hosp Poniente, Serv Urol, El Ejido, Almeria, Spain

:
 Hosp Gen Univ Castellon, Serv Urol, Castellon de La Plana, Spain

Soto, A:
 Hosp Univ Jerez, Serv Urol, Jerez de la Frontera, Spain
ISSN: 02104806





ACTAS UROLOGICAS ESPANOLAS
Editorial
ENE EDICIONES SL, REDACCION, ADMINISTRACION & PUBLICIDAD, ORURO 9 - BAJO IZDA, MADRID, 28016, SPAIN, Reino Unido
Tipo de documento: Article
Volumen: 43 Número: 7
Páginas: 364-370
WOS Id: 000486735900004
ID de PubMed: 31097211

MÉTRICAS